Henan Lingrui Pharmaceutial Co., Ltd. Class ASSE: 600285

Report for Q3 2024

Oct 30, 2024 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment